✦ LIBER ✦
Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)
✍ Scribed by Carmen D. Schweighofer; Matthias Ritgen; Barbara F. Eichhorst; Raymonde Busch; Wolfgang Abenhardt; Michael Kneba; Michael Hallek; Clemens-Martin Wendtner
- Book ID
- 108676006
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 112 KB
- Volume
- 144
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.